INTERNATIONAL PATENT: SERPENTIDE INC. FILES APPLICATION FOR "SUPER LONG-LASTING GLP1 OR GLP1/GIP ANALOGUE DRUGFOR TYPE-2 DIABETES AND OBESITY"

GENEVA, Sept. 8 -- SERPENTIDE INC. (Suite 410, Building 3, Times High-Tech Industrial Park, 1688 Tianma Rd, Xiaoshan DistrictHangzhou, Zhejiang 311258) filed a patent application (PCT/CN2025/079205) for "SUPER LONG-LASTING GLP1 OR GLP1/GIP ANALOGUE DRUGFOR TYPE-2 DIABETES AND OBESITY" on Feb 26, 2025. With publication no. WO/2025/180387, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WEI, Yang (30 Granite Springs RdNew York 10598)

Abstract: Provided are a GLP1 analogue and GLP1/GIP receptor co-agonist analogues, a fus...